Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,049,545
New position
Shares Held
78,500
first reported quarter
Ownership
0.459%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIL Ltd holds $1,155,975,399 across 27 Biotechnology names. RNA ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
2,339,192 | $268,586,025 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
309,509 | $239,139,033 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
12,560,028 | $181,618,004 | |
| 4 | INSM |
INSMED Inc
|
828,947 | $135,549,413 | |
| 5 | ASND |
Ascendis Pharma A/S
|
447,421 | $102,338,605 | |
| 6 | DAWN |
Day One Biopharmaceuticals, Inc.
|
4,131,907 | $88,588,086 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,140,000 | $45,862,200 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
91,499 | $30,274,273 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,049,545 | 78,500 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||